Clinical trials recruiting for Chronic Lymphocytic Leukemia
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Ibrutinib | 1 |
| Nicotinamide | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| New York | 3 |
| California | 2 |
| Connecticut | 2 |
| Georgia | 2 |
| Illinois | 2 |
| Indiana | 2 |
| Kansas | 2 |
| Kentucky | 2 |
| Massachusetts | 2 |
| Michigan | 2 |
| Minnesota | 2 |
| Missouri | 2 |
Top cities
Self-screener
Recruiting trials
- A Long-term Extension Study of PCI-32765 (Ibrutinib)
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers
- Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study
- Evaluation of Skin Tests in Biotherapy Allergies
- Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors
Related conditions
Trials recruiting for Chronic Lymphocytic Leukemia often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Chronic Lymphocytic Leukemia trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.